Retrospective assessment of a serum proteomic test in a Phase III study comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in previously treated patients with advanced non-small cell lung cancer

Buttigliero, C; F A, Shepperd; Barlesi, F; Shwartz, B; Orlov, S; A G, Favaretto; Santoro, A; Hirsch, V; Ramlau, R; A R, Blackler; Roder, J; Spigel, D; Novello, S; Akerlev, W; G V, Scagliotti

doi:10.1634/theoncologist

Retrospective assessment of a serum proteomic test in a Phase III study comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in previously treated patients with advanced non-small cell lung cancer / Buttigliero C; Shepperd F A; Barlesi F; Shwartz B; Orlov S; Favaretto A G; Santoro A; Hirsch V; Ramlau R; Blackler A R; Roder J; Spigel D; Novello S; Akerlev W; Scagliotti G V. - In: THE ONCOLOGIST. - ISSN 1083-7159. - 24:6(2019), pp. e251-e259.

Titolo:	Retrospective assessment of a serum proteomic test in a Phase III study comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in previously treated patients with advanced non-small cell lung cancer
Autori:	Buttigliero C Shepperd F A Barlesi F Shwartz B Orlov S Favaretto A G SANTORO, Armando Hirsch V Ramlau R Blackler A R Roder J Spigel D Novello S Akerlev W Scagliotti G V mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2019
Rivista:	THE ONCOLOGIST
Handle:	http://hdl.handle.net/11699/1833
Appare nelle tipologie:	1.1 Articolo in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11699/1833

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: